{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:52:49Z","timestamp":1776905569714,"version":"3.51.2"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100016237","name":"Armauer Hansen Research Institute","doi-asserted-by":"publisher","award":["T-10"],"award-info":[{"award-number":["T-10"]}],"id":[{"id":"10.13039\/100016237","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13050-x","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:33:03Z","timestamp":1773664383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of the activation status of T lymphocyte subpopulations in peripheral blood from localized and diffused cutaneous leishmaniasis patients at the University of Gondar Hospital, Ethiopia"],"prefix":"10.1186","volume":"26","author":[{"given":"Teshager","family":"Dubie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menberework","family":"Chanyalew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tekalign","family":"Deressa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abay","family":"Atnafu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demeke Geremew","family":"Debebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadelo Wondmagegn","family":"Melese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Adem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dareskedar","family":"Tsehay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melat","family":"Woldemariam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Zewdie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Endalamaw","family":"Gadisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rawleigh","family":"Howe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"issue":"5","key":"13050_CR1","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, V\u00e9lez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, Boer Md, Team WLC. Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE. 2012;7(5):e35671.","journal-title":"PLoS ONE"},{"issue":"17\u201318","key":"13050_CR2","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/S0264-410X(02)00769-7","volume":"21","author":"E Dumonteil","year":"2003","unstructured":"Dumonteil E, Jesus R-SM, Javier E-O. del Rosario G-MM: DNA vaccines induce partial protection against Leishmania mexicana. Vaccine. 2003;21(17\u201318):2161\u20138.","journal-title":"Vaccine"},{"issue":"5","key":"13050_CR3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1365-3083.2012.02764.x","volume":"76","author":"J Mutiso","year":"2012","unstructured":"Mutiso J, Macharia J, Gicheru M. Immunization with leishmania vaccine-alum\u2010BCG and montanide ISA 720 adjuvants induces low\u2010grade type 2 cytokines and high levels of IgG2 subclass antibodies in the vervet monkey (Chlorocebus aethiops) model. Scand J Immunol. 2012;76(5):471\u20137.","journal-title":"Scand J Immunol"},{"issue":"1","key":"13050_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.actatropica.2011.04.007","volume":"119","author":"J Kaur","year":"2011","unstructured":"Kaur J, Kaur T, Kaur S. Studies on the protective efficacy and immunogenicity of Hsp70 and Hsp83 based vaccine formulations in Leishmania donovani infected BALB\/c mice. Acta Trop. 2011;119(1):50\u20136.","journal-title":"Acta Trop"},{"issue":"2","key":"13050_CR5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1128\/JCM.05061-11","volume":"50","author":"N Veland","year":"2012","unstructured":"Veland N, Boggild AK, Valencia C, Valencia BM, Llanos-Cuentas A, Van der Auwera G, Dujardin J-C, Arevalo J. Leishmania (Viannia) species identification on clinical samples from cutaneous leishmaniasis patients in peru: assessment of a molecular stepwise approach. J Clin Microbiol. 2012;50(2):495\u20138.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"13050_CR6","doi-asserted-by":"publisher","first-page":"e56177","DOI":"10.1371\/journal.pone.0056177","volume":"8","author":"MA Marlow","year":"2013","unstructured":"Marlow MA, da Silva Mattos M, Makowiecky ME, Eger I, Rossetto AL, Grisard EC, Steindel M. Divergent profile of emerging cutaneous leishmaniasis in subtropical Brazil: new endemic areas in the southern frontier. PLoS ONE. 2013;8(2):e56177.","journal-title":"PLoS ONE"},{"key":"13050_CR7","unstructured":"WHO. Weekly epidemiological record. 2016;91:285\u2013296."},{"issue":"5","key":"13050_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","volume":"27","author":"P Desjeux","year":"2004","unstructured":"Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004;27(5):305\u201318.","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"4","key":"13050_CR9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.exppara.2006.09.014","volume":"115","author":"E Gadisa","year":"2007","unstructured":"Gadisa E, Genetu A, Kuru T, Jirata D, Dagne K, Aseffa A, Gedamu L. Leishmania (Kinetoplastida): Species typing with isoenzyme and PCR\u2013RFLP from cutaneous leishmaniasis patients in Ethiopia. Exp Parasitol. 2007;115(4):339\u201343.","journal-title":"Exp Parasitol"},{"issue":"2","key":"13050_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.exppara.2010.04.026","volume":"126","author":"E Gadisa","year":"2010","unstructured":"Gadisa E, Kuru T, Genet A, Engers H, Aseffa A, Gedamu L. Leishmania donovani complex (Kinetoplastida, Trypanosomatidae): comparison of deoxyribonucleic acid based techniques for typing of isolates from Ethiopia. Exp Parasitol. 2010;126(2):203\u20138.","journal-title":"Exp Parasitol"},{"key":"13050_CR11","doi-asserted-by":"crossref","unstructured":"Modabber F, Buffet PA, Torreele E, Milon G, Croft SL. Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Kinetoplastid Biol Dis. 2007;6(1):3.","DOI":"10.1186\/1475-9292-6-3"},{"issue":"9","key":"13050_CR12","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.trstmh.2008.03.021","volume":"102","author":"E Negera","year":"2008","unstructured":"Negera E, Gadisa E, Yamuah L, Engers H, Hussein J, Kuru T, Hailu A, Gedamu L, Aseffa A. Outbreak of cutaneous leishmaniasis in Silti woreda, Ethiopia: risk factor assessment and causative agent identification. Trans R Soc Trop Med Hyg. 2008;102(9):883\u201390.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"13050_CR13","volume-title":"Addis Ababa, Ethiopia","author":"Report of the Fifth Consultative Meeting onLeishmania\/HIV Coinfection","year":"2010","unstructured":"Report of the Fifth Consultative Meeting onLeishmania\/HIV Coinfection. Addis Ababa, Ethiopia. In World Health Organization; 2010."},{"key":"13050_CR14","doi-asserted-by":"publisher","first-page":"111671","DOI":"10.1016\/j.biopha.2021.111671","volume":"139","author":"EK Elmahallawy","year":"2021","unstructured":"Elmahallawy EK, Alkhaldi AA, Saleh AA. Host immune response against leishmaniasis and parasite persistence strategies: a review and assessment of recent research. Biomed Pharmacother. 2021;139:111671.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"13050_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/tropicalmed7040054","volume":"7","author":"AC Costa-da-Silva","year":"2022","unstructured":"Costa-da-Silva AC, Nascimento DO, Ferreira JR, Guimar\u00e3es-Pinto K, Freire-de-Lima L, Morrot A, Decote-Ricardo D, Filardy AA. Freire-de-Lima CG: immune responses in leishmaniasis: an overview. Trop Med Infect disease. 2022;7(4):54.","journal-title":"Trop Med Infect disease"},{"key":"13050_CR16","doi-asserted-by":"crossref","unstructured":"Fowler EA, Novais FO. Step-by-step: the CD8 T cell journey in leishmaniasis. mBio. 2025:e03537-23.","DOI":"10.1128\/mbio.03537-23"},{"issue":"9","key":"13050_CR17","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nri.2016.72","volume":"16","author":"P Scott","year":"2016","unstructured":"Scott P, Novais FO. Cutaneous leishmaniasis: immune responses in protection and pathogenesis. Nat Rev Immunol. 2016;16(9):581\u201392.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"13050_CR18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.humimm.2009.01.007","volume":"70","author":"LR Castellano","year":"2009","unstructured":"Castellano LR, Correia Filho D, Argiro L, Dessein H, Prata A, Dessein A, Rodrigues V. Th1\/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-\u03b3 production. Hum Immunol. 2009;70(6):383\u201390.","journal-title":"Hum Immunol"},{"issue":"7","key":"13050_CR19","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.imbio.2008.11.009","volume":"214","author":"A Varin","year":"2009","unstructured":"Varin A, Gordon S. Alternative activation of macrophages: immune function and cellular biology. Immunobiology. 2009;214(7):630\u201341.","journal-title":"Immunobiology"},{"issue":"8","key":"13050_CR20","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1096\/fj.04-3416fje","volume":"19","author":"P Kropf","year":"2005","unstructured":"Kropf P, Fuentes JM, F\u00e4hnrich E, Arpa L, Herath S, Weber V, Soler G, Celada A, Modolell M, M\u00fcller I. Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. FASEB J. 2005;19(8):1000\u20132.","journal-title":"FASEB J"},{"issue":"3","key":"13050_CR21","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1365-2249.1994.tb07015.x","volume":"95","author":"L Kestens","year":"1994","unstructured":"Kestens L, Vanham G, Vereecken C, Vandenbruaene M, Vercauteren G, Colebunders R, Gigase P. Selective increase of activation antigens HLA-DR and CD38 on CD45RO\u2009+\u2009T lymphocytes during HIV-1 infection. Clin Experimental Immunol. 1994;95(3):436\u201341.","journal-title":"Clin Experimental Immunol"},{"issue":"1","key":"13050_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12981-021-00330-6","volume":"18","author":"L Lu","year":"2021","unstructured":"Lu L, Wang J, Yang Q, Xie X, Huang Y. The role of CD38 in HIV infection. AIDS Res therapy. 2021;18(1):11.","journal-title":"AIDS Res therapy"},{"issue":"3","key":"13050_CR23","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1128\/IAI.68.3.1428-1434.2000","volume":"68","author":"M Nashleanas","year":"2000","unstructured":"Nashleanas M, Scott P. Activated T cells induce macrophages to produce NO and control Leishmania major in the absence of tumor necrosis factor receptor p55. Infect Immun. 2000;68(3):1428\u201334.","journal-title":"Infect Immun"},{"issue":"1","key":"13050_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev.iy.13.040195.001055","volume":"13","author":"SL Reiner","year":"1995","unstructured":"Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol. 1995;13(1):151\u201377.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"13050_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1365-3083.2012.02748.x","volume":"76","author":"P Freitas-Teixeira","year":"2012","unstructured":"Freitas-Teixeira P, Silveira\u2010Lemos D, Giunchetti R, Baratta\u2010Masini A, Mayrink W, Peruhype\u2010Magalh\u00e3es V, Rocha R, Campi\u2010Azevedo A, Teixeira\u2010Carvalho A, Martins\u2010Filho O. Distinct pattern of immunophenotypic features of innate and adaptive immunity as a putative signature of clinical and laboratorial status of patients with localized cutaneous leishmaniasis. Scand J Immunol. 2012;76(4):421\u201332.","journal-title":"Scand J Immunol"},{"issue":"4","key":"13050_CR26","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1128\/IAI.68.4.1760-1764.2000","volume":"68","author":"S Ajdary","year":"2000","unstructured":"Ajdary S, Alimohammadian MH, Eslami MB, Kemp K, Kharazmi A. Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection. Infect Immun. 2000;68(4):1760\u20134.","journal-title":"Infect Immun"},{"issue":"4","key":"13050_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0001-706X(91)90078-X","volume":"49","author":"A Martinez-Arends","year":"1991","unstructured":"Martinez-Arends A, Tapia F, Caceres-Dittmar G, Mosca W, Valecillos L, Convit J. Immunocytochemical characterization of immune cells in lesions of American cutaneous leishmaniasis using novel T cell markers. Acta Trop. 1991;49(4):271\u201380.","journal-title":"Acta Trop"},{"issue":"2","key":"13050_CR28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1006\/expr.1996.0104","volume":"84","author":"G Bomfim","year":"1996","unstructured":"Bomfim G, Nascimento C, Costa J, Carvalho EM, Barral-Netto M, Barral A. Variation of cytokine patterns related to therapeutic response in diffuse cutaneous leishmaniasis. Exp Parasitol. 1996;84(2):188\u201394.","journal-title":"Exp Parasitol"},{"key":"13050_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fimmu.2012.00005","volume":"3","author":"S St\u00e4ger","year":"2012","unstructured":"St\u00e4ger S, Rafati S. CD8\u2009+\u2009T cells in Leishmania infections: friends or foes? Front Immunol. 2012;3:5.","journal-title":"Front Immunol"},{"key":"13050_CR30","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1590\/abd1806-4841.20142389","volume":"89","author":"CM Gomes","year":"2014","unstructured":"Gomes CM, de Paula NA, Morais OOd, Soares KA, Roselino AM, Sampaio RNR. Complementary exams in the diagnosis of American tegumentary leishmaniasis. An Bras Dermatol. 2014;89:701\u20139.","journal-title":"An Bras Dermatol"},{"key":"13050_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.eclinm.2018.12.009","volume":"6","author":"S van Henten","year":"2018","unstructured":"van Henten S, Adriaensen W, Fikre H, Akuffo H, Diro E, Hailu A, Van der Auwera G, van Griensven J. Cutaneous leishmaniasis due to Leishmania aethiopica. EClinicalMedicine. 2018;6:69\u201381.","journal-title":"EClinicalMedicine"},{"issue":"12","key":"13050_CR32","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/j.1365-3024.2007.00991.x","volume":"29","author":"J Ruiz","year":"2007","unstructured":"Ruiz J, Becker I. CD8 cytotoxic T cells in cutaneous leishmaniasis. Parasite Immunol. 2007;29(12):671\u20138.","journal-title":"Parasite Immunol"},{"issue":"11","key":"13050_CR33","doi-asserted-by":"publisher","first-page":"e871","DOI":"10.1371\/journal.pntd.0000871","volume":"4","author":"J Hern\u00e1ndez-Ruiz","year":"2010","unstructured":"Hern\u00e1ndez-Ruiz J, Salaiza-Suazo N, Carrada G, Escoto S, Ruiz-Remigio A, Rosenstein Y, Zentella A, Becker I. CD8 cells of patients with diffuse cutaneous leishmaniasis display functional exhaustion: the latter is reversed, in vitro, by TLR2 agonists. PLoS Negl Trop Dis. 2010;4(11):e871.","journal-title":"PLoS Negl Trop Dis"},{"key":"13050_CR34","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3389\/fimmu.2018.01021","volume":"9","author":"DH Barroso","year":"2018","unstructured":"Barroso DH, Falc\u00e3o SDAC, Motta JdOCd, Sevilha dos Santos L, Takano GHS, Gomes CM, Favali CBF, De Lima BD, Sampaio RNR. PD-L1 may mediate T-cell exhaustion in a case of early diffuse leishmaniasis caused by Leishmania (L.) amazonensis. Front Immunol. 2018;9:1021.","journal-title":"Front Immunol"},{"key":"13050_CR35","doi-asserted-by":"crossref","unstructured":"Mueller SN, Ahmed R. High antigen levels are the cause of T cell exhaustion during chronic viral infection. Proc Natl Acad Sci U S A. 2009;106(21):8623\u20138628.","DOI":"10.1073\/pnas.0809818106"},{"issue":"1","key":"13050_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/imr.12823","volume":"292","author":"C Fenwick","year":"2019","unstructured":"Fenwick C, Joo V, Jacquier P, Noto A, Banga R, Perreau M, Pantaleo G. T-cell exhaustion in HIV infection. Immunol Rev. 2019;292(1):149\u201363.","journal-title":"Immunol Rev"},{"key":"13050_CR37","doi-asserted-by":"publisher","first-page":"632667","DOI":"10.3389\/fimmu.2021.632667","volume":"12","author":"R Garcia de Moura","year":"2021","unstructured":"Garcia de Moura R, Covre LP, Fantecelle CH, Gajardo VAT, Cunha CB, Stringari LL, Belew AT, Daniel CB, Zeidler SVV, Tadokoro CE. PD-1 blockade modulates functional activities of exhausted-like T cell in patients with cutaneous leishmaniasis. Front Immunol. 2021;12:632667.","journal-title":"Front Immunol"},{"issue":"1","key":"13050_CR38","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12879-015-0799-x","volume":"15","author":"R Ferraz","year":"2015","unstructured":"Ferraz R, Cunha CF, Gomes-Silva A, Schubach AO, Pimentel MIF, Lyra MR, Mendon\u00e7a SC, Valete-Rosalino CM, Da-Cruz AM, Bertho \u00c1L. Apoptosis and frequency of total and effector CD8\u2009+\u2009T lymphocytes from cutaneous leishmaniasis patients during antimonial therapy. BMC Infect Dis. 2015;15(1):74.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"13050_CR39","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1186\/s13071-023-06057-9","volume":"16","author":"GA Amare","year":"2023","unstructured":"Amare GA, Mekonnen GG, Kassa M, Addisu A, Kendie DA, Tegegne B, Abera A, Tadesse D, Getahun S, Wondmagegn YM. First report of cutaneous leishmaniasis caused by Leishmania donovani in Ethiopia. Parasites Vectors. 2023;16(1):457.","journal-title":"Parasites Vectors"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13050-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13050-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13050-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:19:57Z","timestamp":1776903597000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13050-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13050"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13050-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"15 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of the University of Gondar (IRB, reference SBMLS\/Dec.625\/2017). Informed written consent was obtained from each patient and control participant. Moreover, this study adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"811"}}